Philips ePatch and AI analytics platform rolled out to 14 hospitals across Spain to monitor heart patients
22 Maggio 2024 - 10:00AM
Philips ePatch and AI analytics platform rolled out to 14 hospitals
across Spain to monitor heart patients
May 22, 2024
- Philips wearable ePatch and AI analytics platform help detect
potentially life-threatening irregular heartbeats
- The solution helps University Hospital Vall d’Hebron achieve
reduced average length of stay, relieve emergency room pressure,
and reduce costs
Amsterdam, the Netherlands, and Madrid, Spain –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health
technology, today announced the successful nationwide rollout of
its ambulatory cardiac monitoring service in Spain using its unique
wearable ePatch paired with its AI-driven Cardiologs analytics
platform. 14 Spanish healthcare providers across the country are
now using the company’s ePatch extended wear Holter monitors to
detect life-threatening heart arrhythmias such as atrial
fibrillation (AF). The solution has been proven to detect heart
arrhythmias missed by traditional Holter monitors, enhance patient
comfort, improve care access, and potentially better clinical
outcomes, in addition to reducing overall costs.
Philips’ ePatch provides reliable data for up to 14 days of
continuous monitoring. When paired with Philips’ AI-driven
Cardiologs analytics platform, the solution empowers the hospitals’
cardiology and neurology teams with an end-to-end solution that
enhances their ability to detect and diagnose AF – a potentially
life-threatening [1] cardiac arrhythmia and also the world’s most
common. AF significantly increases the risk of stroke, dementia,
and heart failure, yet often goes undetected due to its lack of
noticeable symptoms and infrequent occurrence intervals.
"The key advantage for healthcare professionals lies in its
user-friendly interface and high-quality 14-day continuous
recording capabilities," said Dr. Jorge Pagola, Neurologist
Postdoctoral Researcher at University Hospital Vall d'Hebron,
Barcelona, Spain. "Applied as a chest patch in just a few minutes,
it seamlessly integrates an analysis program, facilitating swift
examination of recordings. Thanks to its AI-based analysis
assistant, AF events can be classified for rapid review by our
team. Patients experience enhanced comfort as they are free from
cumbersome cables of the conventional Holter, allowing them to
dress, shower, and carry out their daily activities without any
hindrance."
Dr. Jorge Pagola further explains, “Using the ePatch program, we
expedited hospital discharge for 80 patients in 2023. This
initiative led to a reduced average length of stay, relieved
emergency room pressure, and an estimated total cost reduction of €
28.800 in 2023 [2].”
Pilot programs in major hospitals across
SpainIn addition to Hospital Vall d'Hebron, where Philips’
ePatch is being used to detect post-discharge AF in patients, pilot
projects demonstrating the device’s effectiveness in cardiology and
neurology are being conducted at other major hospitals in Madrid,
Barcelona, Bilbao, Alicante, Madrid, Cadiz, and Navarra [3].
Applications include monitoring patients for AF after cardiac
ablation therapy or heart valve replacement procedures, and studies
of the link between magnesium insufficiency and AF.
In some Spanish hospitals, the ease-of-use and cost benefits of
Philips ePatch are helping reduce waiting lists that built up
during the COVID-19 pandemic, making a tangible difference to
people’s access to care. In total, more than 1500 patients are
currently being monitored with Philips ePatch devices in Spain.
“This innovative new service allows clinical teams to
conveniently monitor patients as they go about their everyday
activities for extended periods of time, collecting the real-life
data that helps reveal the patient’s true condition,” said Miquel
Barras, Ambulatory Monitoring & Diagnostics Lead for Philips in
Spain.
In a recent US study comparing the diagnostic abilities of 7-day
and 14-day monitoring with Philips’ extended wear ePatch compared
to conventional 24-hour Holter monitoring, the ePatch detected 2x
more clinically significant heart arrhythmias during 7 days of
monitoring and more than 2.5x as many over 14 days [4].
[1] Heart.org[2] Data on file in hospital Vall d'Hebron[3]
Madrid: Hospital Universitario Fundación Jiménez
Díaz, Hospital Universitario Infanta Elena, Hospital de La
Princesa, University Hospital Quironsalud Madrid, Hospital
Universitario Rey Juan Carlos. Barcelona: Vall
d'Hebron University Hospital, Hospital Clínic de Barcelona,
Hospital de Sant Joan Despí Moisès Broggi, Hospital Sant Joan de
Déu Barcelona, Hospital Universitari de Bellvitge, Hospital de Sant
Pau. Bilbao: Hospital Universitario Cruces.
Alicante: Hospital General Universitario de Elche.
Cadiz: Hospital Universitario De Jerez.
Navarra: Hospital General de Navarra.[4] Parikh,
P, Grigoriadis, C, Dunn, A. et al. Diagnostic Yield of 24-hour
Holter vs 7-day and 14-day ePatch Extended Wear Holter. J Am Coll
Cardiol. 2023 Mar, 81 (8_Supplement) 149. Research conducted by
Philips ECG
Solutions.https://doi.org/10.1016/S0735-1097(23)00593-4
For further information, please contact:
César García RequenaPhilips IbéricaTel: +34 670
264 471Email: cesar.garcia.requena@philips.com
Joost Maltha External RelationsTel: +31 6 10 55
8116 Email: joost.maltha@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health
technology company focused on improving people's health and
well-being through meaningful innovation. Philips’ patient- and
people-centric innovation leverages advanced technology and deep
clinical and consumer insights to deliver personal health solutions
for consumers and professional health solutions for healthcare
providers and their patients in the hospital and the
home. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, ultrasound, image-guided therapy,
monitoring and enterprise informatics, as well as in personal
health. Philips generated 2023 sales of EUR 18.2 billion and
employs approximately 69,100 employees with sales and services in
more than 100 countries. News about Philips can be found
at www.philips.com/newscenter.
- Woman wearing Philips ePatch
- Philips ePatch
- Dr. Jorge Pagola Val dHebron
- Philips Cardiologs AI analytics platform
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Koninklijke Philips NV (EU:PHIA)
Storico
Da Nov 2023 a Nov 2024
